Retinal haemodynamics in patients with age-related macular degeneration

Eye

Volumn 20, Issue 6, 2006, Pages 697-702

  Sato, E ^a   Feke, G T ^a   Menke, M N ^a   Wallace McMeel, J ^a  

^a Retina Associates Boston   (United States)

Author keywords

Age related macular degeneration; Laser Doppler; Pulsatility indices; Retinal haemodynamics

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERIAL CIRCULATION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; LASER DOPPLER FLOWMETRY; MALE; RETINA; RETINA ARTERY; RETINA MACULA AGE RELATED DEGENERATION; VASCULAR RESISTANCE;

EID: 33745066938     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701951     Document Type: Article

References (26)

1. Tomany SC, Wang JJ, van Leenwen R, Klein R, Mitchell P, Vingerling JR et al. Risk factors for incident age-related macular degeneration. Pooled findings from 3 continents. Ophthalmology 2004; 111: 1280-1287.
2. Ciulla TA, Harris A, Chung HS, Danis RP, Kagemann L, McNulty L et al. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol 1999; 128: 75-80.
3. Hosal BM, Karakoç G, Gürsel E, Çamur M. Color Doppler imaging of the retrobulbar circulation in age-related macular degeneration. Eur J Ophthalmol 1998; 8: 234-238.
4. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 1995; 102: 640-646.
5. Dimitrova G, Tamaki Y, Kato S. Retrobulbar circulation in patients with age-related maculopathy. Eye 2002; 16: 580-586.
6. Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 1998; 39: 385-390.
7. The Age-Related Eye Disease Study Research Group. The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The age-related eye disease study report. Number 6. Am J Ophthalmol 2001; 132: 668-681.
8. Yoshida A, Feke GT, Mori F, Nagaoka T, Fujio N, Ogasawara H et al. Reproducibility and clinical application of a new developed stabilized retinal laser Doppler instrument. Am J Ophthalmol 2003; 135: 356-361.
9. Pourcelot L. Indications de l'ultrasonographie Doppler dans l'etude des vaisseaux peripheriques. Rev Prat 1975; 25: 4671-4680.
10. Medeiros NE, Curcio CA. Preservation of ganglions cell layer neurons in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001; 42: 795-803.
11. Polska E, Kircher K, Ehrlich P, Vecsel PV, Schmetterer L. RI in central retinal artery as assessed by CDI does not correspond to retinal vascular resistance. Am J Physiol 2001; 280: H1442-H1447.
12. Bude R, Rubin J. Relationship between the resistive index and vascular compliance and resistance. Radiology 1999; 211: 411-417.
13. Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy. Ophthalmology 2003; 110: 636-643.
14. Chong NHV, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, Wolf RL et al. Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol 2005; 166: 241-251.
15. Martyn CN, Greenwald SE. Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 1997; 350: 953-955.
16. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995; 142: 404-409.
17. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: The Rotterdam study. Invest Ophthalmol Vis Sci 2003; 44: 3771-3777.
18. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthal Epidemiol 1999; 6: 125-143.
19. AREDS Research Group. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the age-related eye disease study. AREDS Report No. 13. Arch Ophthalmol 2004; 122: 716-726.
20. Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D et al. Case-control study of the risk factors for age related macular degeneration. Br J Ophthalmol 1998; 82: 996-1002.
21. McGwin Jr G, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. Br J Ophthalmol 2003; 87: 1121-1125.
22. Wilson HL, Schwartz DM, Bhatt HRF, Mcculoch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rate of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004; 137: 615-624.
23. Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN. Risk of macular degeneration in users of statins: Cross sectional study. BMJ 2001; 323: 375-376.
24. Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol 1997; 124: 677-682.
25. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 2000; 130: 658-663.
26. Friedman E. Update of the vascular model of AMD. Br J Ophthalmol 2004; 88: 161-163.